Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00702507 · ClinicalTrials.gov registry record · Phase 4
Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants
A Phase 4 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
NCT00702507 is a Phase 4 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 200 participants.
The verdict
NCT00702507, a Phase 4 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether repeated use of 0.25% miconazole nitrate ointment in newborns and infants with a yeast infection in the diaper area causes the yeast to become resistant to the drug.
Interventions
- DRUG 0.25 % Miconazole Nitrate Ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00702507
The ClinicalTrials.gov registry entry for NCT00702507 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stiefel, a GSK Company, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 0.25 % Miconazole Nitrate Ointment is the first listed.
NCT00702507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00702507 about?
NCT00702507 is a clinical study titled "Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants". The purpose of this study is to determine whether repeated use of 0.25% miconazole nitrate ointment in newborns and infants with a yeast infection in the diaper area causes the yeast to become resistant to the drug.
What is the current status of trial NCT00702507?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2007-05. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00702507?
The interventions under investigation include: 0.25 % Miconazole Nitrate Ointment (DRUG).
Who is sponsoring clinical trial NCT00702507?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.